XTL Biopharmaceuticals Ltd. - ADR (XTLB)
Market Closed
16 Jun, 20:00
$
2. 38
+0.08
+3.4783%
$
5.04M Market Cap
- P/E Ratio
- Div Yield
8,320 Volume
0 Eps
$ 2.3
Previous Close Want to track XTLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | 0.09 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.24 |
| | | - | 0 |
| | | - | - |
| | | - | - |
XTLB Earnings Reports FAQ
What is the earnings per share (EPS) for XTLB?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 46.16%, reflecting the XTLB's performance and NASDAQ (CM) market conditions.
When is the next earnings release date?
XTL Biopharmaceuticals Ltd. - ADR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for XTL Biopharmaceuticals Ltd. - ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for XTLB at this time, as XTL Biopharmaceuticals Ltd. - ADR has no recent EPS data to calculate it.
